Answers are grounded in this paper and cite their sources.
The study uncovers how late-stage cancer malignancy arises from therapeutic resistance and limits of oncogenic drivers.
Traditional oncology has long been dominated by mutation-centric paradigms, framing cancer as a cumulative genetic error. However, these models often fail to explain phenotypic convergence and therapeutic resistance in advanced stages. This paper proposes a thermodynamic reinterpretation based on the Theorem of Axiomatic Necessity (TNA), arguing that late-stage cancer is not a product of genetic novelty but a consequence of entropy export failure. By applying the fundamental TNA equation ({d}{dt} = G - Psi), we demonstrate that once cellular throughput (Psi) collapses, the resulting incoherence accumulation (aleph) forces a regression from specialized functional structures (N^1) to a primitive, high-entropy survival state (N^0). In this framework, late-stage malignancy is viewed as a post-genetic entropic regression where thermodynamic constraints on viability override specific oncogenic drivers. This model shifts the focus from gene-list variation to the mechanical restoration of throughput, offering testable predictions for microenvironmental influence on tumor stability.
No takes yet. Share an insight, caveat, or question.
Claudio Bresciano (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: